- Hong Kong
- /
- Healthcare Services
- /
- SEHK:2293
Do Its Financials Have Any Role To Play In Driving Bamboos Health Care Holdings Limited's (HKG:2293) Stock Up Recently?
Bamboos Health Care Holdings (HKG:2293) has had a great run on the share market with its stock up by a significant 14% over the last week. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to study its financial indicators more closely to see if they had a hand to play in the recent price move. Specifically, we decided to study Bamboos Health Care Holdings' ROE in this article.
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.
How To Calculate Return On Equity?
Return on equity can be calculated by using the formula:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
So, based on the above formula, the ROE for Bamboos Health Care Holdings is:
11% = HK$24m ÷ HK$223m (Based on the trailing twelve months to December 2024).
The 'return' is the profit over the last twelve months. So, this means that for every HK$1 of its shareholder's investments, the company generates a profit of HK$0.11.
See our latest analysis for Bamboos Health Care Holdings
What Has ROE Got To Do With Earnings Growth?
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company’s earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes.
Bamboos Health Care Holdings' Earnings Growth And 11% ROE
To start with, Bamboos Health Care Holdings' ROE looks acceptable. On comparing with the average industry ROE of 7.1% the company's ROE looks pretty remarkable. For this reason, Bamboos Health Care Holdings' five year net income decline of 4.9% raises the question as to why the high ROE didn't translate into earnings growth. Based on this, we feel that there might be other reasons which haven't been discussed so far in this article that could be hampering the company's growth. Such as, the company pays out a huge portion of its earnings as dividends, or is faced with competitive pressures.
That being said, we compared Bamboos Health Care Holdings' performance with the industry and were concerned when we found that while the company has shrunk its earnings, the industry has grown its earnings at a rate of 8.6% in the same 5-year period.
The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about Bamboos Health Care Holdings''s valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.
Is Bamboos Health Care Holdings Using Its Retained Earnings Effectively?
Bamboos Health Care Holdings' declining earnings is not surprising given how the company is spending most of its profits in paying dividends, judging by its three-year median payout ratio of 64% (or a retention ratio of 36%). With only a little being reinvested into the business, earnings growth would obviously be low or non-existent. You can see the 3 risks we have identified for Bamboos Health Care Holdings by visiting our risks dashboard for free on our platform here.
In addition, Bamboos Health Care Holdings has been paying dividends over a period of at least ten years suggesting that keeping up dividend payments is way more important to the management even if it comes at the cost of business growth.
Summary
Overall, we feel that Bamboos Health Care Holdings certainly does have some positive factors to consider. Although, we are disappointed to see a lack of growth in earnings even in spite of a high ROE. Bear in mind, the company reinvests a small portion of its profits, which means that investors aren't reaping the benefits of the high rate of return. Until now, we have only just grazed the surface of the company's past performance by looking at the company's fundamentals. You can do your own research on Bamboos Health Care Holdings and see how it has performed in the past by looking at this FREE detailed graph of past earnings, revenue and cash flows.
Valuation is complex, but we're here to simplify it.
Discover if Bamboos Health Care Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:2293
Bamboos Health Care Holdings
An investment holding company, provides healthcare staffing solutions in Hong Kong.
Excellent balance sheet established dividend payer.
Market Insights
Community Narratives

